Tag Archives: drugmakers’

Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19

The COVID-19 pandemic has tested pharma’s supply chain and spawned several drug shortages. Now, with mental health suffering, antidepressant Zoloft and its generics are in short supply. A number of drugmakers are having trouble keeping up with higher demand, while some can’t get their hands on active pharmaceutical ingredients (APIs) to make the medicine, the… Read More »

Inside drugmakers’ strategy to boost cancer medicines with ‘Lazarus effect’

(Reuters) – In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus effect” in some patients because it can reverse late-stage cancer that has defied all other treatment options. FILE PHOTO: Logo of Bayer AG is pictured ahead of the the annual results news conference of the German… Read More »